FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.
The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...
FOX 8 News on MSN
Recalled tuna accidently shipped to stores in Ohio: FDA
The U.S. Food and Drug Administration is warning consumers that previously recalled canned tuna was recently shipped to ...
Machina Medical, Corp. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company, today announced that the U.S. Food and ...
FDA grants Priority Review and assigns a PDUFA goal date of July 17, 2026 MINNEAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing ...
According to an announcement shared by the Food & Drug Administration (FDA) on Jan. 19, 2026, Tri-Union Seafoods is ...
At a Food and Drug Administration cell and gene therapy (CGT) roundtable last June, most speakers pushed for the agency to ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
Valneva withdrew its chikungunya vaccine applications following a license suspension and data suggesting a probable link to serious adverse outcomes.
7hon MSN
Recalled Tuna Alert: Full List of Stores and States Affected by FDA Notice on Genova Canned Tuna
The FDA has warned that previously recalled Genova canned tuna was mistakenly shipped back to stores in multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback